1. Tanton, Helen, Sewastianik, Tomasz, Seo, Hyuk-Soo, Dhe-Paganon, Sirano, Carrasco, Ruben D. 2022. A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. In Science advances, 8, eabm3108. doi:10.1126/sciadv.abm3108. https://pubmed.ncbi.nlm.nih.gov/35486727/
2. Gu, Zhaohui, Churchman, Michelle, Roberts, Kathryn, Hunger, Stephen P, Mullighan, Charles G. 2016. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia. In Nature communications, 7, 13331. doi:10.1038/ncomms13331. https://pubmed.ncbi.nlm.nih.gov/27824051/
3. Feng, Mei, Wu, Zhongen, Zhou, Yan, Wang, Ming-Wei, Zhu, Di. 2021. BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer. In Signal transduction and targeted therapy, 6, 313. doi:10.1038/s41392-021-00730-0. https://pubmed.ncbi.nlm.nih.gov/34417435/
4. Chatziandreou, Ilenia, Psaraki, Adriana, Paschidis, Konstantinos, Lazaris, Andreas C, Saetta, Angelica A. 2021. Evidence for frequent concurrent DCUN1D1, FGFR1, BCL9 gene copy number amplification in squamous cell lung cancer. In Pathology, research and practice, 221, 153412. doi:10.1016/j.prp.2021.153412. https://pubmed.ncbi.nlm.nih.gov/33862557/
5. Suzuki, Kyogo, Okuno, Yusuke, Kawashima, Nozomu, Kato, Koji, Kojima, Seiji. 2016. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents. In Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34, 3451-9. doi:10.1200/JCO.2016.66.5547. https://pubmed.ncbi.nlm.nih.gov/27507882/
智鼠故事 
